Breaking News Instant updates and real-time market news.

NVRO

Nevro

$60.70

-7.305 (-10.74%)

09:53
07/13/18
07/13
09:53
07/13/18
09:53

Nevro falls almost 13% after VP of world wide sales James Alecxih terminated

The company said that on July 9, Nevro determined to terminate James Alecxih's, VP Worldwide Sales, employment with the company. Shares are down 12.5% or $8.52 to 59.52 in early trading.

  • 27

    Aug

NVRO Nevro
$60.70

-7.305 (-10.74%)

07/02/18
07/02/18
DOWNGRADE
Target $88

Equal Weight
Nevro downgraded to Equal Weight on lower commercial momentum at Morgan Stanley
As previously reported, Morgan Stanley analyst David Lewis downgraded Nevro to Equal Weight from Overweight, stating that Nevro's commercial message on clinically superiority has not resonated and competitors have gained traction, blunting the company's share gains. There is also a risk that Saluda's large-scaled randomized EVOKE study could show similar or better efficacy than Senza, Lewis added. He lowered his 2019 revenue estimate for Nevro by 3%, to 2% below consensus, and cut his price target on the shares to $88 from $94.
07/02/18
07/02/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Canon (CAJ) downgraded to Sell from Neutral at Goldman Sachs with analyst Satoru Ogawa recommending a cautious stance on the Japanese precision equipment sector due to "high valuations and flagging earnings momentum." 2. Integra LifeSciences (IART) downgraded to Neutral from Buy at Citi with analyst Amit Haza saying he sees limited upside following the recent rally in the shares. 3. Nevro (NVRO) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Lewis stating that Nevro's commercial message on clinically superiority has not resonated and competitors have gained traction, blunting the company's share gains. 4. Nordstrom (JWN) downgraded to Market Perform from Outperform at Cowen with analyst Oliver Chen citing the stock's current valuation after its recent run, his view of a likely lack of near-term upside to full-line sales and store traffic, and the need for improvements at the Rack division. 5. Las Vegas Sands (LVS) downgraded to Neutral from Buy at BofA/Merrill with analyst Shaun Kelley saying June was the second month of weaker than expected GGR growth, there are continued mixed reads from the firm's Macau Macro Activity Tracker, and weaker FX and trade fears have increased uncertainty. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/18
WELS
07/11/18
NO CHANGE
WELS
Market Perform
Nevro IP concerns appear overblown, says Wells Fargo
Wells Fargo analyst Larry Biegelsen notes that last week, a contentious hearing was held in the Northern District of California in the litigation where Nevro (NVRO) is asserting that Boston Scientific (BSX) infringes seven patents related to high-frequency stimulation. News coverage of the hearing has understandably focused on the fact that the judge expressed significant skepticism with respect to many of the Nevro patents and this news coverage has likely lead to a 15.1% drop in Nevro's share price on July 10, he adds. Biegelsen's patent consultant, however, believes Nevro is very likely to emerge in good shape, despite the headlines. The analyst reiterates a Market Perform rating on Nevro's shares.
07/11/18
JPMS
07/11/18
NO CHANGE
JPMS
Overweight
JPMorgan more positive on Nevro positioning in legal fight after management talk
JPMorgan analyst Robert Marcus said that after his talks with Nevro's (NVRO) management team he is more positive on the company's positioning in its ongoing legal fight against Boston Scientific (BSX). Headlines regarding a tentative ruling that supported invalidating 5 of the 7 patents at issue, which he attributes for Nevro's decline yesterday, masked that the judge favored Nevro on the two remaining patents and the company only needs to successfully defend one of its patents to keep Boston Scientific out of the market, Marcus tells investors. He maintains an Overweight rating on Nevro shares.

TODAY'S FREE FLY STORIES

KRYS

Krystal Biotech

$19.73

4.24 (27.37%)

11:52
10/15/18
10/15
11:52
10/15/18
11:52
Recommendations
Krystal Biotech analyst commentary  »

Krystal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

HBAN

Huntington Bancshares

$14.35

-0.02 (-0.14%)

11:50
10/15/18
10/15
11:50
10/15/18
11:50
Options
Huntington Bancshares attracts call buyers »

Huntington Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

11:50
10/15/18
10/15
11:50
10/15/18
11:50
General news
Treasury's $84 B 3- and 6-month bill sales were mixed, but generally lackluster »

Treasury's $84 B 3-…

OXY

Occidental Petroleum

$73.69

-3.24 (-4.21%)

11:48
10/15/18
10/15
11:48
10/15/18
11:48
Hot Stocks
Occidental confirms it will no longer pursue contract extension for ISND »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CENX

Century Aluminum

$10.30

0.14 (1.38%)

11:45
10/15/18
10/15
11:45
10/15/18
11:45
Options
Century Aluminum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

11:45
10/15/18
10/15
11:45
10/15/18
11:45
General news
Former Fed Chair Yellen said 3% growth is great »

Former Fed Chair Yellen…

DUK

Duke Energy

$80.57

0.6 (0.75%)

11:42
10/15/18
10/15
11:42
10/15/18
11:42
Hot Stocks
Duke Energy announces plans for new renewable energy program in South Carolina »

Duke Energy has proposed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 11

    Nov

  • 11

    Nov

ENDP

Endo

$17.62

0.11 (0.63%)

11:35
10/15/18
10/15
11:35
10/15/18
11:35
Options
Endo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 27

    Nov

11:34
10/15/18
10/15
11:34
10/15/18
11:34
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:34
10/15/18
10/15
11:34
10/15/18
11:34
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

LTHM

Livent

$16.11

-0.14 (-0.86%)

11:31
10/15/18
10/15
11:31
10/15/18
11:31
Initiation
Livent initiated  »

Livent initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PX

Praxair

$158.82

2.62 (1.68%)

, LNEGY

Linde

$0.00

(0.00%)

11:27
10/15/18
10/15
11:27
10/15/18
11:27
Hot Stocks
Linde, Praxair announce squeeze-out of remaining Linde shareholders »

Linde (LNEGY) and Praxair…

PX

Praxair

$158.82

2.62 (1.68%)

LNEGY

Linde

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$73.76

-0.73 (-0.98%)

11:25
10/15/18
10/15
11:25
10/15/18
11:25
Conference/Events
Economic Club of Washington, D.C. to hold luncheon meeting »

Luncheon Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

S

Sprint

$6.35

-0.04 (-0.63%)

11:20
10/15/18
10/15
11:20
10/15/18
11:20
Options
Size ratio spread in Sprint »

Size ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

11:20
10/15/18
10/15
11:20
10/15/18
11:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
10/15/18
10/15
11:17
10/15/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAN

Huntington Bancshares

$14.29

-0.08 (-0.56%)

11:17
10/15/18
10/15
11:17
10/15/18
11:17
Technical Analysis
Technical Take: Huntington Bancshares breaks support »

The shares are down 0.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

PAR

PAR Technology

$20.31

-0.69 (-3.29%)

11:16
10/15/18
10/15
11:16
10/15/18
11:16
Hot Stocks
Voss Capital supports ADW's call for PAR Technology board to pursue alternatives »

Voss Capital, LLC, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
10/15/18
10/15
11:16
10/15/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$59.01

-0.67 (-1.12%)

11:15
10/15/18
10/15
11:15
10/15/18
11:15
Options
Weibo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
10/15/18
10/15
11:15
10/15/18
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
10/15/18
10/15
11:15
10/15/18
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:13
10/15/18
10/15
11:13
10/15/18
11:13
Hot Stocks
Breaking Hot Stocks news story  »

Bio Rad Laboratories…

11:10
10/15/18
10/15
11:10
10/15/18
11:10
General news
Treasury announced a $25 B 8-week bill for the inaugural sale Tuesday »

Treasury announced a $25…

TXT

Textron

$65.88

0.81 (1.24%)

11:06
10/15/18
10/15
11:06
10/15/18
11:06
Hot Stocks
TRU Simulation + Training, FlightSafety International enter LOI to form JV »

TRU Simulation +…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.